Herrera, J <br/><br/>
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Apr 2001 
 - 750-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6838 
<br/><br/><label>Standard No.: </label>10.1016/s0272-6386(01)80124-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia--blood<br/>Catalase--blood<br/>Double-Blind Method<br/>Erythrocytes--chemistry<br/>Erythropoietin--administration & dosage<br/>Female<br/>Glutathione--blood<br/>Humans<br/>Infusions, Intravenous<br/>Iron--administration & dosage<br/>Kidney Failure, Chronic--blood<br/>Male<br/>Malondialdehyde--blood<br/>Melatonin--administration & dosage<br/>Oxidative Stress--drug effects<br/>Placebos<br/>Recombinant Proteins<br/>Renal Dialysis<br/>Treatment Outcome